WallStSmart

Lineage, Inc. Common Stock (LINE)vsStar Holdings (STHO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lineage, Inc. Common Stock generates 4433% more annual revenue ($5.36B vs $118.14M). LINE leads profitability with a -1.9% profit margin vs -54.4%. STHO earns a higher WallStSmart Score of 47/100 (D+).

LINE

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 3.5Value: 6.7Quality: 3.8
Piotroski: 5/9Altman Z: 0.81

STHO

Hold

47

out of 100

Grade: D+

Growth: 3.3Profit: 4.5Value: 6.7Quality: 5.0
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LINEUndervalued (+75.9%)

Margin of Safety

+75.9%

Fair Value

$161.49

Current Price

$35.99

$125.50 discount

UndervaluedFair: $161.49Overvalued
STHOUndervalued (+79.7%)

Margin of Safety

+79.7%

Fair Value

$39.50

Current Price

$8.57

$30.93 discount

UndervaluedFair: $39.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LINE1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

STHO2 strengths · Avg: 10.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Operating MarginProfitability
45.1%10/10

Strong operational efficiency at 45.1%

Areas to Watch

LINE4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-1.2%2/10

ROE of -1.2% — below average capital efficiency

Revenue GrowthGrowth
-0.2%2/10

Revenue declined 0.2%

Altman Z-ScoreHealth
0.812/10

Distress zone — elevated risk

STHO4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.8%4/10

1.8% revenue growth

Market CapQuality
$101.42M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.073/10

Elevated debt levels

Return on EquityProfitability
-23.2%2/10

ROE of -23.2% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : LINE

The strongest argument for LINE centers on Price/Book.

Bull Case : STHO

The strongest argument for STHO centers on Price/Book, Operating Margin.

Bear Case : LINE

The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.

Bear Case : STHO

The primary concerns for STHO are Revenue Growth, Market Cap, Debt/Equity.

Key Dynamics to Monitor

STHO is growing revenue faster at 1.8% — sustainability is the question.

LINE generates stronger free cash flow (78M), providing more financial flexibility.

Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

STHO scores higher overall (47/100 vs 36/100). LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lineage, Inc. Common Stock

REAL ESTATE · REIT - INDUSTRIAL · USA

Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.

Visit Website →

Star Holdings

REAL ESTATE · REAL ESTATE SERVICES · USA

Star Holdings engages in the non-ground lease related commercial real estate businesses in the United States. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?